ASMANEX
400MCG INH PLV 30DÁV II
SÚKL code | 0232290 |
---|---|
Name of the product | ASMANEX |
_MA_MEDICATION_DETAIL_INFO_MED_NAME i | ASMANEX |
Supplement | 400MCG INH PLV 30DÁV II |
Strenght | 400MCG |
Pharmaceutical form | Inhalation powder |
Package | 30DÁV II |
Route | Inhalation use |
Language of the pack | Czech |
Wrap type | Metering valve |
Legal status | na lékařský předpis |
Active substance | MOMETASONE FUROATE (MOMETASONI FUROAS) |
ATC group | R03BA07 |
ATC group name | MOMETASON |
Marketing authorisation information
Registration Number | 14/ 531/00-C |
---|---|
Type of MA | National |
MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
Placed on the market till | 28. 02. 2022 |
MA Holder | Merck Sharp & Dohme B.V., Haarlem |
MA Holder country | NIZOZEMSKO |
Actual MA holder | N.V. Organon, Oss |
Actual MA holder country | NIZOZEMSKO |